Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: Evaluation of a Regional System to Increase Access to Cooling

• Published in: Circulation (New York, N.Y.) N.Y.), 2011-07, Vol.124 (2), p.206-214
• Main Authors: MOONEY, Michael R, UNGER, Barbara T, HODGES, James S, PARHAM, William M, BOLAND, Lori L, NICHOLAS BURKE, M, KEBED, Kalie Y, GRAHAM, Kevin J, HENRY, Timothy D, KATSIYIANNIS, William T, SATTERLEE, Paul A, SENDELBACH, Sue
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac - mortality; Arrhythmias, Cardiac - therapy; Biological and medical sciences; Blood and lymphatic vessels; Cardiology. Vascular system; Disease-Free Survival; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous; Heart; Heart failure, cardiogenic pulmonary edema, cardiac enlargement; Humans; Hypothermia, Induced - methods; Hypothermia, Induced - standards; Hypothermia, Induced - utilization; Male; Medical sciences; Middle Aged; Out-of-Hospital Cardiac Arrest - mortality; Out-of-Hospital Cardiac Arrest - therapy; Risk Factors; Shock, Cardiogenic - mortality; Shock, Cardiogenic - therapy; Survival Rate
• ISSN: 0009-7322; 1524-4539
• DOI: 10.1161/CIRCULATIONAHA.110.986257

Therapeutic hypothermia (TH) improves survival and confers neuroprotection in out-of-hospital cardiac arrest (OHCA), but TH is underutilized, and regional systems of care for OHCA that include TH are needed. The Cool It protocol has established TH as the standard of care for OHCA across a regional network of hospitals transferring patients to a central TH-capable hospital. Between February 2006 and August 2009, 140 OHCA patients who remained unresponsive after return of spontaneous circulation were cooled and rewarmed with the use of an automated, noninvasive cooling device. Three quarters of the patients (n=107) were transferred to the TH-capable hospital from referring network hospitals. Positive neurological outcome was defined as Cerebral Performance Category 1 or 2 at discharge. Patients with non-ventricular fibrillation arrest or cardiogenic shock were included, and patients with concurrent ST-segment elevation myocardial infarction (n=68) received cardiac intervention and cooling simultaneously. Overall survival to hospital discharge was 56%, and 92% of survivors were discharged with a positive neurological outcome. Survival was similar in transferred and nontransferred patients. Non-ventricular fibrillation arrest and presence of cardiogenic shock were associated strongly with mortality, but survivors with these event characteristics had high rates of positive neurological recovery (100% and 89%, respectively). A 20% increase in the risk of death (95% confidence interval, 4% to 39%) was observed for every hour of delay to initiation of cooling. A comprehensive TH protocol can be integrated into a regional ST-segment elevation myocardial infarction network and achieves broad dispersion of this essential therapy for OHCA.